A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients With Breast Cancer Treated With Vaginal Estrogen, Estring
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Estradiol (Primary)
- Indications Genitourinary disorders
- Focus Pharmacodynamics
- 16 Nov 2017 Planned End Date changed from 30 Jun 2017 to 30 Jun 2018.
- 03 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Jan 2014 Status changed from not yet recruiting to recruiting according to ClinicalTrial.gov record.